Vaccines Vector
Studies add new findings to vaccines vector body of knowledge
Published in Gene Therapy Weekly, December 1st, 2005
Study 1: Adenovirus vectors provide efficient gene transfer into embryonic stem cells.
"Efficient and transient gene transfer into embryonic stem (ES) cells is expected to be of use for basic studies in developmental biology and for applications in regenerative medicine. Here, we report the development of an adenovirus (Ad) vector that efficiently expresses foreign genes in mouse ES (mES) cells. We prepared four LacZ-expressing Ad vectors, each of which contained one of the following: Rous sarcoma virus (RSV), cytomegalovirus (CMV), beta-actin promoter/CMV enhancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-12-01)
More Articles from Gene Therapy Weekly
- Gene Research
Vascular endothelial growth factor gene change enhances safety of gene therapy - Gene Research
sFlt-1 gene therapy halts pathological neovascularization in animal eyes - Macular Degeneration
RS1 gene therapy aids X-linked juvenile retinoschisis murine models - Peripheral Vascular Disease
Gene therapy promotes arteriogenic and angiogenic responses in ischemic limbs - Antibacterial Agents
REP8839 antibacterial activity is due to inhibition of a methionyl-tRNA synthetase - Atherogenesis
Human paraoxonase-3 can be cloned and highly expressed - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
